152 related articles for article (PubMed ID: 10868866)
1. Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes.
Vidal J; Fernández-Balsells M; Sesmilo G; Aguilera E; Casamitjana R; Gomis R; Conget I
Diabetes Care; 2000 Mar; 23(3):360-4. PubMed ID: 10868866
[TBL] [Abstract][Full Text] [Related]
2. High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.
Schnell O; Eisfelder B; Standl E; Ziegler AG
Diabetes; 1997 Oct; 46(10):1607-11. PubMed ID: 9313757
[TBL] [Abstract][Full Text] [Related]
3. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
[TBL] [Abstract][Full Text] [Related]
4. Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients.
Mendola G; Casamitjana R; Gomis R
Diabetologia; 1989 Mar; 32(3):160-2. PubMed ID: 2526767
[TBL] [Abstract][Full Text] [Related]
5. [Chronic complications in adult patients with newly diagnosed diabetes mellitus in relation to the presence of humoral autoimmune markers against pancreatic islet cells].
Szepietowska B; Szelachowska M; Górska M; Jakubczyk D; Kinalska I
Pol Arch Med Wewn; 2004 May; 111(5):563-9. PubMed ID: 15508807
[TBL] [Abstract][Full Text] [Related]
6. A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus.
Crinó A; Schiaffini R; Ciampalini P; Suraci MC; Manfrini S; Visalli N; Matteoli MC; Patera P; Buzzetti R; Guglielmi C; Spera S; Costanza F; Fioriti E; Pitocco D; Pozzilli P;
J Pediatr Endocrinol Metab; 2005 Aug; 18(8):749-54. PubMed ID: 16200840
[TBL] [Abstract][Full Text] [Related]
7. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).
Pozzilli P; Visalli N; Signore A; Baroni MG; Buzzetti R; Cavallo MG; Boccuni ML; Fava D; Gragnoli C; Andreani D
Diabetologia; 1995 Jul; 38(7):848-52. PubMed ID: 7556988
[TBL] [Abstract][Full Text] [Related]
8. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus.
Bonfanti R; Bazzigaluppi E; Calori G; Riva MC; Viscardi M; Bognetti E; Meschi F; Bosi E; Chiumello G; Bonifacio E
Diabet Med; 1998 Oct; 15(10):844-50. PubMed ID: 9796885
[TBL] [Abstract][Full Text] [Related]
9. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
10. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
Dittler J; Seidel D; Schenker M; Ziegler AG
Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study).
Pozzilli P; Visalli N; Cavallo MG; Signore A; Baroni MG; Buzzetti R; Fioriti E; Mesturino C; Fiori R; Romiti A; Giovannini C; Lucentini L; Matteoli MC; Crinò A; Teodonio C; Paci F; Amoretti R; Pisano L; Suraci C; Multari G; Suppa M; Sulli N; De Mattia G; Faldetta MR
Eur J Endocrinol; 1997 Sep; 137(3):234-9. PubMed ID: 9330586
[TBL] [Abstract][Full Text] [Related]
12. Cellular immune response to diverse islet cell antigens in IDDM.
Durinovic-Bellò I; Hummel M; Ziegler AG
Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX).
Crinò A; Schiaffini R; Manfrini S; Mesturino C; Visalli N; Beretta Anguissola G; Suraci C; Pitocco D; Spera S; Corbi S; Matteoli MC; Patera IP; Manca Bitti ML; Bizzarri C; Pozzilli P;
Eur J Endocrinol; 2004 May; 150(5):719-24. PubMed ID: 15132730
[TBL] [Abstract][Full Text] [Related]
14. Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving beta-cell function at onset of type 1 diabetes mellitus.
Recasens M; Aguilera E; Morínigo R; Casamitjana R; Nicoletti F; Gomis R; Conget I
Diabetes Res Clin Pract; 2003 Jun; 60(3):153-9. PubMed ID: 12757987
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
Ongagna JC; Levy-Marchal C
Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
[TBL] [Abstract][Full Text] [Related]
16. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune markers in young Malaysian patients with type 1 diabetes mellitus.
Nazaimoon WM; Azmi KN; Rasat R; Ismail IS; Singaraveloo M; Mohamad WB; Letchuman R; Sheriff IH; Faridah I; Khalid BA
Med J Malaysia; 2000 Sep; 55(3):318-23. PubMed ID: 11200711
[TBL] [Abstract][Full Text] [Related]
18. A trial of nicotinamide in newly diagnosed patients with type 1 (insulin-dependent) diabetes mellitus.
Chase HP; Butler-Simon N; Garg S; McDuffie M; Hoops SL; O'Brien D
Diabetologia; 1990 Jul; 33(7):444-6. PubMed ID: 2144835
[TBL] [Abstract][Full Text] [Related]
19. GAD treatment and insulin secretion in recent-onset type 1 diabetes.
Ludvigsson J; Faresjö M; Hjorth M; Axelsson S; Chéramy M; Pihl M; Vaarala O; Forsander G; Ivarsson S; Johansson C; Lindh A; Nilsson NO; Aman J; Ortqvist E; Zerhouni P; Casas R
N Engl J Med; 2008 Oct; 359(18):1909-20. PubMed ID: 18843118
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics, GAD antibody (GADA) and change of C-peptide in Korean young age of onset diabetic patients.
Ahn CW; Kim HS; Nam JH; Song YD; Lim SK; Kim KR; Lee HC; Huh KB
Diabet Med; 2002 Mar; 19(3):227-33. PubMed ID: 11918625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
